Kestra Medical Technologies, LTD. key statistics and ratios

In fiscal 2026, Kestra Medical Technologies, LTD. had return on equity of -56.6%, an operating margin of -141.6%, debt equal to 16.4% of equity and a current ratio of 4.41. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.

Financial ratios

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Kestra Medical Technologies, LTD.: financial ratios, annual
Fiscal year	2024Apr 2024	2025Apr 2025	2026Apr 2026	LTMJul 2026
Gross margin	1.3%	40.5%	51.4%	53.9%
Operating margin	−305.8%	−177.8%	−141.6%	−134.5%
Net margin	−338.4%	−190.3%	−138.4%	−140.4%
Free-cash-flow margin	−303.7%	−168.1%	−122.6%	−115.0%
Return on equity	—	—	−56.6%	−62.2%
Return on assets	−204.8%	−66.6%	−40.2%	−42.5%
Asset turnover	0.61	0.35	0.29	0.30
Current ratio	0.45	6.72	4.41	4.69
Debt to equity	—	20.0%	16.4%	32.6%
Interest cover (operating income ÷ interest)	n/m	n/m	n/m	n/m
R&D as % of revenue	55.7%	26.2%	20.5%	20.9%
SG&A as % of revenue	251.4%	192.2%	172.5%	167.5%
Capital spending as % of revenue	44.0%	38.3%	36.7%	32.9%

US$ thousands unless shown otherwise. Fiscal quarters.

Kestra Medical Technologies, LTD.: financial ratios, quarterly
Quarter	2025 Q2Oct 2024	2025 Q3Jan 2025	2025 Q4Apr 2025	2026 Q1Jul 2025	2026 Q2Oct 2025	2026 Q3Jan 2026	2026 Q4Apr 2026	2027 Q1Jul 2026
Gross margin	39.6%	43.4%	44.3%	45.7%	50.6%	52.6%	54.8%	56.5%
Operating margin	−130.1%	−136.5%	−279.8%	−149.1%	−140.7%	−141.6%	−137.4%	−121.6%
Net margin	−138.5%	−142.5%	−302.1%	−133.3%	−145.3%	−139.2%	−135.6%	−142.3%
Free-cash-flow margin	−153.0%	−146.2%	−182.5%	−177.8%	−113.5%	−114.7%	−99.1%	−131.2%
Current ratio	—	—	6.72	6.84	5.47	7.32	4.41	4.69
Debt to equity	—	—	20.0%	22.5%	25.5%	14.7%	16.4%	32.6%
R&D as % of revenue	23.9%	22.2%	31.3%	20.7%	21.6%	20.3%	19.7%	21.9%
SG&A as % of revenue	145.9%	157.7%	292.8%	174.1%	169.7%	173.9%	172.5%	156.1%

Returns use average equity or assets over the year. Return on equity is left blank when equity is negative or so small that the ratio says nothing (above ±200%); interest cover is left blank above 200 times. Price-based ratios such as P/E are on the valuation page.

Financial health

3 of 6 checks passed · July 31, 2026

What it owns · $347m

Short-term assets $226mLonger-term assets $121m

What it owes, and who funded it · $347m

Short-term liabilities $48mLonger-term liabilities $77mShareholders' equity $222m

Short-term assets cover short-term liabilities $226m of assets due within a year against $48m of liabilities due within a year.
Short-term assets cover long-term liabilities $226m short-term assets against $77m of longer-dated liabilities.
More cash than debt $69m of cash against $72m of debt.
Debt below 40% of shareholders' equity Debt is 33% of equity.
Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
A year's operating cash flow covers at least 20% of debt −$88m of operating cash flow against $72m of debt.
Operating profit covers interest at least five times over Operating income of −$144m against $8m of interest.

From Kestra Medical Technologies, LTD.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Low.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Compare with peers

Head to head: KMTS vs XTNT KMTS vs SMTI CBLL vs KMTS

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Kestra Medical Technologies, LTD.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Kestra Medical Technologies, LTD.